In a retrospective analysis of patients with peripheral artery disease from a single-payer system, endovascular revascularization was associated with fewer costs than open surgery or primary ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. CHICAGO — In patients with chronic limb-threatening ...

New analysis of chronic limb-threatening ischemia (CLTI) treatment outcomes was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) ...

Long Beach, Calif. – May 3, 2024 – New clinical results highlight the need for inclusive approaches and comprehensive examinations of treatment options for peripheral artery disease (PAD), including ...

In patients with acute ischemic stroke undergoing contemporary endovascular therapy, timely treatment and achievement of successful revascularization are key to good functional outcome and reduced ...

The treatment of peripheral artery disease (PAD) focuses on risk factor modification, cardiovascular event reduction, limb viability, and symptom improvement. Hypertension, hyperlipidemia, and ...

DALLAS, TX—The combination of endovascular revascularization plus supervised exercise therapy in patients with peripheral artery disease (PAD) and intermittent claudication results in greater ...

Among patients with peripheral artery disease and intermittent claudication (cramping pain in the legs due to poor circulation in the arteries, aggravated by walking), a combination therapy of ...

Atherosclerotic renal artery stenosis (RAS) is relatively common and often associated with hypertension and progressive renal insufficiency. Technical improvements of interventional endovascular tools ...

Endovascular therapy is increasingly used after the administration of intravenous tissue plasminogen activator (t-PA) for patients with moderate-to-severe acute ischemic stroke, but whether a combined ...

SAN JOSE, Calif., September 29, 2025--(BUSINESS WIRE)--AngioSafe ® today announced its emergence from stealth with 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its flagship ...